𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Electrophysiological evaluation of visual pathways in paclitaxel-treated patients

✍ Scribed by V. Scaioli; A. Caraceni; C. Martini; S. Curzi; G. Capri; G. Luca


Publisher
Springer US
Year
2005
Tongue
English
Weight
426 KB
Volume
77
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Electrophysiologic evaluation of the vis
✍ Jelka Brecelj; Branka Stirn-Kranjc πŸ“‚ Article πŸ“… 1992 πŸ› Springer-Verlag 🌐 English βš– 456 KB

Clinical findings and results of electrophysiologic evaluation of the visual pathway were studied in seven children ranging in age from 10 months to 13 years. Using skin electrodes for electroretinographic and visual evoked potential testing, we obtained reliable results without sedation or pupil di

Electrophysiology of the corticomotoneur
✍ P. D. Thompson; J. P. R. Dick; B. L. Day; J. C. Rothwell; A. Berardelli; T. Kach πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 316 KB

The corticomotoneurone pathways were examined in 21 patients with movement disorders, using the technique of percutaneous electrical stimulation of the motor cortex. Conduction in these pathways was assessed by measuring the latency to onset of electromyographic activity in the muscles of the upper

Hypoperfusion of the visual pathway in p
✍ Hideaki Matsui; Kazuto Nishinaka; Masaya Oda; Narihiro Hara; Kenichi Komatsu; Ta πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 89 KB

## Abstract Little is known about the developing mechanisms of visual hallucinations in Parkinson's disease. This study aimed to investigate perfusion changes in parkinsonian patients with visual hallucinations using __n__‐isopropyl‐__p__‐[^123^I]iodoamphetamine ([^123^I]IMP) single photon emission

Central nervous system progression of me
✍ Ronnie J. Freilich; Andrew D. Seidman; Dr. Lisa M. Deangelis πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 474 KB πŸ‘ 2 views

Background. The possibility of tumor sanctuary sites in the central nervous system (CNS) of patients receiving paclitaxel has been suggested by laboratory data identifying low concentrations of drug in the brain and cerebrospinal fluid (CSF) of rats. Methods. The pattern of disease progression in p